arrow
K

Keiji Nogami

Nara Medical University
H指数:37
被引数:5,475

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors

FRONTIER5:从emicizumab直接转换为denecimig(Mim8)在有无抑制剂的血友病A患者中的安全性与患者体验

2026-09-120
OAAI
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial

伴有因子Ⅷ同时给药在服用依米西单抗预防的A型血友病患者中的凝血潜能(CAGUYAMA研究):一项多中心、开放标签、非随机临床试验

2026-08-010
PRE
Concizumab in hemophilia with inhibitors: Longer-term efficacy and safety results from the phase 3 explorer7 study

康加尼珠单抗在伴抑制物的血友病中的长期疗效和安全性结果:3期EXPLORER7研究

2026-01-120
OAAI
AOZORA study: Three-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis

AOZORA研究:接受emicizumab预防治疗的血友病A患儿人群安全性与关节健康的三年期中期分析

2025-10-210
OAAI
Development of Awareness Materials to Promote Early Diagnosis of Undiagnosed von Willebrand Disease: Integration of Multidisciplinary Perspectives Based on a Literature Review

开发用于促进未诊断范科尼贫血早期诊断的宣传材料:基于文献综述的多学科视角整合

2025-08-080
PRE
TSUBASA Study: evaluation of the quality and content of daily life of people with haemophilia A without factor VIII inhibitors on prophylactic treatment with emicizumab

TSUBASA研究:评估无因子VIII抑制剂的血友病A患者在使用emicizumab预防性治疗下的生活质量和日常活动内容

2025-07-160
OAAI